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Nucleic acid extraction is an important initial step of modern molecular diagnostics.
A variety of methods are available to extract nucleic acids for analysis. The choice
of methods in any laboratory depends on their major sample source and the nature
of the assay.1 Blood, urine, tissue, and body fluid are used in a clinical laboratory,
but fresh or frozen blood is the most widely used specimen for nucleic acid
extraction. Extracted DNAs are applied to clinical analysis such as genotype
analysis, diagnosis of infectious disease, and transplant engraftment assessment.
The first limiting factor of a successful molecular-based diagnosis is nucleic acid
extraction because the process is labor-intensive and is affected by many
interfering sources and inherently scarce amount of target quantity.2 It is very
important to obtain nucleic acid with sufficient amount and good purity. Recently,
many commercial kits for nucleic acid extraction from clinical specimens have
been introduced.3
We aim to compare the efficiency of commercial automated nucleic acid
extraction systems from venous blood for clinical laboratory application. 
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Purpose: The extraction of nucleic acid is initially a limiting step for successful molecular-based diagnostic workup.
This study aims to compare the effectiveness of three automated DNA extraction systems for clinical laboratory
use. Materials and Methods: Venous blood samples from 22 healthy volunteers were analyzed using QIAamp®
Blood Mini Kit (Qiagen), MagNA Pure LC Nucleic Acid Isolation Kit I (Roche), and Magtration-Magnazorb DNA
common kit-200N (PSS). The concentration of extracted DNAs was measured by NanoDrop ND-1000 (PeqLab).
Also, extracted DNAs were confirmed by applying in direct agarose gel electrophoresis and were amplified by
polymerase chain reaction (PCR) for human beta-globin gene. Results: The corrected concentrations of extracted
DNAs were 25.42 ± 8.82 ng/µL (13.49-52.85 ng/µL) by QIAamp® Blood Mini Kit (Qiagen), and 22.65 ± 14.49
ng/µL (19.18-93.39 ng/µL) by MagNA Pure LC Nucleic Acid Isolation Kit I, and  22.35 ± 6.47 ng/µL (12.57-35.08
ng/µL) by Magtration-Magnazorb DNA common kit-200N (PSS). No statistically significant difference was
noticed among the three commercial kits (p > 0.05). Only the mean value of DNA purity through PSS was slightly
lower than others. All the extracted DNAs were successfully identified in direct agarose gel electrophoresis. And all
the product of beta-globin gene PCR showed a reproducible pattern of bands. Conclusion: The effectiveness of the
three automated extraction systems is of an equivalent level and good enough to produce reasonable results. Each
laboratory could select the automated system according to its clinical and laboratory conditions. 
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INTRODUCTION
Twenty-two samples for genomic DNA extraction from
healthy volunteers
Venous whole blood samples from 22 healthy volunteers
were obtained with K2-EDTA tubes (BD Vacutainer® BD,
Franklin Lakes, NJ, USA). This study was performed with
informed consent from all volunteers and conformed to the
principles of the Helsinki Declaration. 
Genomic DNA extraction
Nucleic acids from each 200 µL of EDTA-whole blood
sample were extracted. After cell lysis and protein dena-
turation, extractions with automated systems were perfor-
med. The final extracted elution volumes were 100 µL by
MagNA Pure LC, 200 µL by Magtration System 12GC,
and 200 µL by QIAcube (Qiagen, Hiden, Germany). 
Nucleic acid extraction with automated systems
QIAamp® Blood Mini Kit with QIAcube 
QIAamp® Blood Mini Kit (Qiagen, Hilden, Germany)
with QIAcube (Qiagen) uses spin column technology.
From the 200 µL input volume of EDTA-whole blood
sample, a final 200 µL extracted volume was obtained. The
steps were as follows: Samples were lysed and heated in
the orbital shaker. Each lysate was transferred to a spin
column in a rotor adapter and if the lysate needed to be
homogenized or cleared, it was transferred to the middle
position of the rotor adapter. Nucleic acids were bound to
the silica membranes or purification resins of the spin
column and washed to remove contaminants. The spin
column was transferred to a collection tube for elution of
purified nucleic acids.
MagNA Pure LC Nucleic Acid Isolation Kit I with 
MagNA Pure LC
MagNA Pure LC Nucleic Acid Isolation Kit I with MagNA
Pure LC (Roche Diagnostics, GmbH, Mannheim, Germany)
is based on magnetic-bead technology with a special buffer
containing chaotropic salts and proteinase K. Nucleic acids
are bound to the surface of the magnetic glass particles.
Cellular debris were removed by several washing steps
and the purified nucleic acids were eluted. From the 200
µL input volume of EDTA-whole blood, 100 µL output
volume of extracted genomic DNA product was obtained,
after the magnetic beads were separated from the solution.
We used corrected concentrations of extracted DNAs
because the final extracted volume of MagNA Pure LC
Nucleic Acid Isolation Kit I was smaller than those of
other kits.  
Magtration-Magnazorb DNA common kit-200N with
Magtration System 12GC
Magtration-Magnazorb DNA common kit-200N with
Magtration System 12GC [Precision System Science
(PSS) Co. Ltd., Chiba, Japan] adopts the principle of
magnetic particle-based technology. The basic steps were
as follows: Target cells were lysed by chaotropic reagents,
causing the release of nucleic acids which then was absorb-
ed on magnetic silica beads under high-ionic-strength
conditions. Each nucleic acid could be selectively captured
by changing the ionic strength. Unbound free proteins,
nucleic acids, and other small cellular debris were removed
by washing with 70% ethanol. Bound nucleic acid could
be eluted from the beads with H2O or a low ionic strength
buffer. This system used magnetic beads which were
aggregated by applying a magnet to the narrow portion of
a tip. The separation and resuspension of magnetic parti-
cles were performed within the disposable tip. On this
study, from 200 µL input volume of whole blood, we got
200 µL volume of extracted DNA. 
Measurement of nucleic acid concentration and purity
The concentrations of extracted DNAs were measured by
NanoDrop ND-1000 spectrophotometer (PeqLab, Erlangen,
Germany). The NanoDrop ND-1000 is a full-spectrum
spectrophotometer for measuring the absorbance of DNA,
RNA, protein, and dye. It can measure a spectrum ranging
from 220 to 750 nm automatically. The spectrum measure-
ment is then performed with 2 optical fibers installed in the
pedestal (emitting light of a Xenon lamp) and the sample
arm (spectrometer with linear CCD array). DNA, RNA,
protein, or dye in 1.5 µL volume can be measured without
cuvettes or capillaries. DNA concentration and optical
density (OD) ratio at 260/280 nm to evaluate purity of
DNA1 were calculated at the same time. 
Electrophoresis of extracted DNAs for confirmation 
The quality of the extracted nucleic acids by three automat-
ed systems was confirmed by direct gel loading and was
amplified by PCR for human beta-globin gene. After
quantifying the extracted nucleic acids by NanoDrop, the
products were directly loaded into the 0.8% agarose gel
with molecular markers. Reproducibility of each system
was evaluated by loading the extracted DNAs from the
same sample. For internal control human beta-globin gene
identification was performed by PCR (Primers and reagents
from Bioneer, Daejeon, Korea). We also used premix Accu-
Power HF PCR PreMix (Bioneer), containing forward
primer 1.0 µL, backward primer 1.0 µL, and extracted DNA
2.0 µL (total 20 µL volume). The human beta-globin gene
was amplified with forward (5’-ACACAACTGTGTTCA
CTAAC-3’) and reverse (5’-CAACTTCATCCACGTTCA
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Table 1. Characteristics of Three DNA Extraction Systems for Genomic DNA Extraction from Venous Blood 
Samples
Company Unit Qiagen Roche PSS




Qiagen blood MagNA pure LC Magtration-MagaZorb
mini kit DNA Isolation kit I DNA Common Kit-200N
Automation Full Full Full
Principle Spin column Magnetic particle Magnetic particle
Runtime by 
Minute 5.08 2.81 2.5
manufacturer / sample
Runtime by 
Minute 5.25 4.55 3.3
this study / sample
Maximum sample 
Number 12 32 12
number / load
Table 2. Results of Genomic DNA Extraction from Whole Blood Samples by Three Automated Systems
Kit name QIAamp blood mini kit
Magna LC Nucleic Magtration-Magnazorb
(input / output
Acid Isolation Kit I DNA common kit-200N
volume) 









#1 21.64 ng/µL 1.93 18.88 ng/µL 1.93 14.96 ng/µL 1.60
#2 32.86 ng/µL 1.82 23.78 ng/µL 1.83 26.65 ng/µL 1.78
#3 32.20 ng/µL 1.91 25.51 ng/µL 1.91 26.53 ng/µL 1.77
#4 21.34 ng/µL 1.82 19.92 ng/µL 1.97 13.91 ng/µL 1.70
#5 18.87 ng/µL 1.83 20.68 ng/µL 1.90 15.27 ng/µL 1.71
#6 26.37 ng/µL 1.86 24.18 ng/µL 1.88 25.71 ng/µL 1.72
#7 24.21 ng/µL 1.99 22.98 ng/µL 1.90 22.09 ng/µL 1.70
#8 25.64 ng/µL 1.75 18.27 ng/µL 1.92 18.64 ng/µL 1.69
#9 22.54 ng/µL 1.82 21.47 ng/µL 1.93 28.62 ng/µL 1.73
#10 15.32 ng/µL 1.92 16.99 ng/µL 1.91 16.50 ng/µL 1.65
#11 19.74 ng/µL 1.86 17.50 ng/µL 1.88 21.24 ng/µL 1.63
#12 35.61 ng/µL 1.85 30.51 ng/µL 1.89 34.39 ng/µL 1.70
#13 27.93 ng/µL 1.71 29.00 ng/µL 1.95 23.17 ng/µL 1.66
#14 23.23 ng/µL 2.04 21.38 ng/µL 1.87 26.41 ng/µL 1.62
#15 52.85 ng/µL 1.59 25.78 ng/µL 1.91 22.00 ng/µL 1.67
#16 20.26 ng/µL 1.87 19.97 ng/µL 1.89 19.19 ng/µL 1.56
#17 21.94 ng/µL 1.81 28.54 ng/µL 1.90 21.77 ng/µL 1.65
#18 33.03 ng/µL 1.83 9.59 ng/µL 1.71 35.08 ng/µL 1.76
#19 13.49 ng/µL 1.86 16.20 ng/µL 1.60 12.57 ng/µL 1.79
#20 14.62 ng/µL 1.79 16.52 ng/µL 1.90 15.72 ng/µL 1.65
#21 34.01 ng/µL 1.90 46.70 ng/µL 1.95 31.57 ng/µL 1.85
#22 21.51 ng/µL 1.82 24.06 ng/µL 1.90 19.68 ng/µL 1.90
Mean ± SD 25.42 ± 8.82 ng/µL 1.84 ± 0.09 22.66 ± 7.24 ng/µL 1.88 ± 0.08 22.35 ± 6.47 ng/µL 1.70 ± 0.08
Range 
13.49 - 52.85 ng/µL 1.59 - 2.04 9.59 - 46.70 ng/µL 1.60 12.57 - 35.08 ng/µL 1.56 - 1.90
(min-max)
*Corrected DNA concentration = [elution volume (100 µL)×DNA quantity by NanoDrop ND-1000)] / sample volume (200 µL).
CC-3’) primers with the reaction parameters; 94˚C, 5 min
and 94˚C, 30 sec, and 53˚C, 30 sec for 30 cycles, and 72˚C,
5 min for extension. PCR products were separated on 2.0%
agarose gel and visualized by ethidium bromide staining. 
Statistical analysis
The mean and standard deviation (SD) were calculated for
all measurements and one-way analysis of variance
(ANOVA) with Tukey’s Honestly Significant Differences
(HSD) post hoc tests were performed with the results.
Pearson’s correlation coefficient was used for unders-
tanding the correlations between the extracted DNAs of
each commercial extraction kit. We estimated the correla-
tion between each extraction method. A p value less than
0.05 was considered as significantly statistically different.
Statistical analysis was performed by SPSS 12.0 (SPSS
Inc., Chicago, IL, USA). 
Concentrations and purity of extracted DNAs 
The characteristics of three DNA extraction systems for
genomic DNA from ethylenediaminetetraacetic acid
(EDTA)-blood samples were summarized in Table 1. All
of the concentrations (ng/µL) and purity (A260/A280) of
extracted DNA from 22 whole blood samples were quan-
tified by NanoDrop ND-1000 (Table 2). The average con-
centration of the total extracted DNAs by three commer-
cial kits was 23.47 ± 7.58 (mean ± SD) ng/µL (min-max,
9.59-52.85 ng/µL). There’s no statistical difference in the
corrected concentration of extracted DNAs (p > 0.05)
among the three commercial kits, i.e., QIAamp® Blood
Mini Kit (25.42 ± 8.82, 13.49-52.85 ng/µL), MagNA Pure
LC Nucleic Acid Isolation Kit I (22.65 ± 14.49, 19.18-93.39
ng/µL), and Magtration-Magnazorb DNA common kit-
200N Magtration System 12GC [Precision System Science
(PSS) Co. Ltd.] (22.35 ± 6.47, 12.57-35.08 ng/µL). 
The mean purity and range of extracted DNAs (A260/
A280) of each kit was 1.84 ± 0.09, 1.59-2.04 by Qiagen,
1.88 ± 0.81, 1.60-1.97 by Roche, and 1.70 ± 0.08, 1.56-
1.90 by PSS. 
Comparisons of the concentration of extracted DNA by
each automated system
Pearson’s correlation coefficient (r) was 0.43 (p = 0.045)
between Qiagen and Roche; between Qiagen and PSS was
0.6 (p = 0.003); and between Roche and PSS was 0.39 (p =
0.069) (Fig. 1). 
Downstream applications
Regardless of the concentration of extracted DNAs, band
patterns of them in direct agarose gel applications (0.8%
agarose) (Fig. 2A) and post human beta-globin gene poly-
merase chain reaction (PCR) products (2.0% agarose) (Fig.
2B) were performed to evaluate the quality and quantity of
extracted nucleic acids. Consistent band patterns of ex-
tracted DNAs (Fig. 3A) and post beta-globin gene PCR
products were identified (Fig. 3B) from the same samples. 
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Recently, in the clinical laboratory the number of items
and samples of molecular testing were rapidly increasing
because many molecular methods have been adopted in
modern medicine. The aim of this study is to evaluate the
efficiency of automated DNA extraction systems for a
clinical diagnostic laboratory. Three systems were selected
because they could be used in clinical application and have
appropriate capacity for our work load.
Venous blood sample is the most common clinical
specimens for molecular diagnosis. It was reported that
more than 70% of the original high-molecular weight
DNA (> 25 kb) can be recovered from blood stored for 3
days with EDTA or acid citrate dextrose (ACD), even
when stored at room temperature.4 Generally, both EDTA
and ACD specimen tubes provide good yields of nucleic
acid for PCR and other assays.1 Garg, et al. suggested that
freezing the blood clot had no measurable effect on the
quantity or purity of the DNA extracted.5 Recently, com-
mercial DNA extraction kits with automated devices were
launched to overcome large demands of clinical laboratory.
Our data could be helpful to adopt automated DNA extrac-
tion systems for a clinical laboratory.
We measured the concentration of extracted DNAs
through NanoDrop ND-1000, direct gel applications, and
beta-globin gene PCR product identification. All testing
parameters showed generally good results. Magtration-
Magnazorb RNA common kit-N200 (PSS) showed relati-
vely lower purity, compared to the other kits, but it was not
beyond an acceptable range. In general, the ratio of A260/
A280 is acceptable purity between 1.6-2.0.6, 7
This lower purity might be caused by contamination
with organic solvents or proteins, they could lower optical
density (OD), and also prevent accurate nucleic acid quan-
Jong-Han Lee, et al.
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DISCUSSION
Fig. 2. Images of the DNA extracts and PCR products by three automated extraction systems. (A) Electrophoresis of DNA extracts by three
automated DNA extraction systems in 0.8% agarose gel, 0.5% tris-borate-EDTA (L1, L2, M1, M2, H1; lowest, 2nd lowest, middle 1, middle 2, highest
DNA quantity). (B) Electrophoresis of beta globin gene PCR products by three automated DNA extraction systems in 2% agarose gel, 0.5% tris-
borate-EDTA (L1, L2, M1, M2, H1; lowest, 2nd lowest, middle 1, middle 2, highest DNA quantity). EDTA, ethylenediaminetetraacetic acid.
A
B
tification from the OD260 reading.1 In addition, cross-
contamination might be caused because of an aerosol.8
There are no published reports of contamination in the
different comparative studies undertaken until now.9 Other
causes of low DNA purity may be due to handling error of
the operator, internal error of the extraction kit, and DNA
calculator. Prospective large scale studies are necessary to
clarify whether this lower purity result using Magtration-
Magnazorb RNA common kit-N200 (PSS) is due to conta-
mination.
For efficient nucleic acid extraction from various speci-
mens, some commercial nucleic acid extraction kits with
automated instruments have been developed for clinical
application.10-15 The choice of a nucleic acid extraction me-
thod depends on several factors, including assay targets
(RNA/DNA-based), specimen type, sample throughput,
laboratory workflow, cost, and the performance of the
extraction system.16 
The commercial nucleic acid extraction kits commonly
adopt magnetic bead or silica matrix technology with a
spin column or vacuum system. In our study, two commer-
cial nucleic acid extraction systems, MagNA Pure LC
nucleic Acid Isolation Kit I (Roche) and Magtration-
Magnazorb RNA common kit-N200 (PSS), were magnetic
bead technologies. In addition, the other Qiagen QIAamp®
Blood Mini Kit (Qiagen) uses spin-column technology for
genomic DNA extraction. In Pearson’s correlation coeffi-
cient comparison, extracted DNAs by QIAamp® Blood
Mini Kit (Qiagen) showed medium positive correlation (r
= 0.43, p = 0.045) with those by MagNA Pure LC nucleic
Acid Isolation Kit I (Roche). Extracted DNAs by QIAamp®
Blood Mini Kit (Qiagen) showed positive correlation (r =
0.6, p = 0.003) with those by Magtration-Magnazorb RNA
common kit-N200 (PSS). Extracted DNAs by MagNA
Pure LC nucleic Acid Isolation Kit I (Roche) did not show
statistically significant correlation (r = 0.39, p = 0.069) with
those by Magtration-Magnazorb RNA common kit-N200
(PSS).   
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Fig. 3. Images of the DNA extracts and PCR products by three automated extraction systems. (A) Electrophoresis of DNA extracts from six sets of
same samples by three automated DNA extraction systems in 0.8% agarose gel, 0.5% tris-borate-EDTA. (B) Electrophoresis of beta-globin gene
PCR products from six sets of same samples by three automated DNA extraction systems in 2% agarose gel, 0.5% tris-borate-EDTA. Q, Qiagen; R,
Roche; P, PSS; EDTA, ethylenediaminetetraacetic acid.
A
B
One of the disadvantages of spin column technology is
that the columns cannot be placed tightly enough into the
collection tubes during centrifugation. Consequently, cross-
contamination of an aerosol may occur.8 Compared to stan-
dard separation procedures, magnetic separation techniques
have several advantages, including simplicity in handling
and high automation potential.17 However, there are still
many disadvantages to all of these methods, such as labor-
intensiveness, limited throughput, and technician dependent
variability in the efficacy of extraction.13 In our study, we
used the corrected concentration of extracted DNAs for
standardized comparison because the final eluted volumes
of each commercial kit were not the same. The corrected
DNA concentrations were calculated by dividing the out-
put elution volume multiplied by DNA concentration by
the input sample volume. The corrected average concen-
tration of extracted DNAs of QIAgen kit was slightly
higher than that of the other commercial kits but did not
show statistically significant differences among the com-
mercial kits in one-way ANOVA analysis. 
The automation of DNA extraction has the advantage of
a standardized sample treatment and avoidance of error
during routine sample handling and contamination due to
intermediate process10,18 However, there are some debates
on the efficiency of DNA extraction methods. Riemann, et
al.3 suggested that the quantity and quality of the genera-
ted DNAs were slightly higher with manual extraction
method than automated extraction method.
In conclusion, the initial limiting step of DNA extraction
for molecular-based diagnostic tests can be successfully
automated with commercial systems with efficient and
good performances. Each laboratory need to consider the
automated system according to its clinical and laboratory
conditions.
1. Bogner PN, Killeen AA. Extraction of nucleic acids. In: Coleman
WB, Tsongalis GJ, editors. Molecular diagnostics for the clinical
laboratorian. 2nd ed. New Jersey: Humana Press; 2006. p.25-30.
2. Edvinsson B, Jalal S, Nord CE, Pedersen BS, Evengård B. DNA
extraction and PCR assays for detection of Toxoplasma gondii.
APMIS 2004;112:342-8.
3. Riemann K, Adamzik M, Frauenrath S, Egensperger R, Schmid
KW, Brockmeyer NH, et al. Comparison of manual and automated
nucleic acid extraction from whole-blood samples. J Clin Labo
Anal 2007;21:244-8.
4. Gustafson S, Proper JA, Bowie EJ, Sommer SS. Parameters
affecting the yield of DNA from human blood. Anal Biochem
1987;165:294-9.
5. Garg UC, Hanson NQ, Tsai MY, Eckfeldt JH. Simple and rapid
method for extraction of DNA from fresh and cryopreserved
clotted human blood. Clin Chem 1996;42:647-8.
6. Saltman DL, Hunger SP, Turner GE. Molecular analysis of chromo-
some aberrations in Hematological Malignancies. In: Gosden JR,
editor. Chromosome Analysis Protocols. New Jersey: Humana
Press; 1994. p.437-48.
7. Mahuku GS. A simple extraction method suitable for PCR-based
analysis of plant, fungal, and bacterial DNA. Plant Molecular
Biology Reporter 2004;22:71-81.
8. Merk S, Meyer H, Greiser-Wilke I, Sprague LD, Neubauer H.
Detection of Burkholderia cepacia DNA from artificially infected
EDTA-blood and lung tissue comparing different DNA isolation
methods. J Vet Med B Infect Dis Vet Public Health 2006;53:281-5.
9. Queipo-Ortuño MI, Tena F, Colmenero JD, Morata P. Compa-
rison of seven commercial DNA extraction kits for the recovery
of Brucella DNA from spiked human serum samples using real-
time PCR. Eur J Clin Microbiol infect Dis 2008;27:109-14.
10. Beuselinck K, van Ranst M, van Eldere J. Automated extraction
of viral-pathogen RNA and DNA for high-throughput quantitative
real-time PCR. J Clin Microbiol 2005;43:5541-6.
11. Leb V, Stöcher M, Valentine-Thon E, Hölzl G, Kessler H, Stekel
H, et al. Fully automated, internally controlled quantification of
hepatitis B Virus DNA by real-time PCR by use of the MagNA
Pure LC and LightCycler instruments. J Clin Microbiol 2004;
42:585-90.
12. Tang YW, Sefers SE, Li H, Kohn DJ, Procop GW. Comparative
evaluation of three commercial systems for nucleic acid extraction
from urine specimens. J Clin Microbiol 2005;43:4830-3.
13. Knepp JH, Geahr MA, Forman MS, Valsamakis A. Comparison
of automated and manual nucleic acid extraction methods for
detection of enterovirus RNA. J Clin Microbiol 2003;41:3532-6.
14. Konnick EQ, Williams SM, Ashwood ER, Hillyard DR. Evalua-
tion of the COBAS Hepatitis C Virus (HCV) TaqMan analyte-
specific reagent assay and comparison to the COBAS Amplicor
HCV Monitor V2.0 and Versant HCV bDNA 3.0 assays. J Clin
Microbiol 2005;43:2133-40.
15. Schrag SJ, Brooks JT, Van Beneden C, Parashar UD, Griffin PM,
Anderson LJ, et al. SARS surveillance during emergency public
health response, United States, March-July 2003. Emerg Infect
Dis 2004;10:185-94.
16. Schuurman T, de Boer R, Patty R, Kooistra-Smid M, van Zwet A.
Comparative evaluation of in-house manual, and commercial
semi-automated and automated DNA extraction platforms in the
sample preparation of human stool specimens for a Salmonella
enterica 5’-nuclease assay. J Microbiol Methods 2007;71:238-45.
17. Kleines M, Schellenberg K, Ritter K. Efficient extraction of viral
DNA and viral RNA by the Chemagic viral DNA/RNA kit allows
sensitive detection of cytomegalovirus, hepatitis B virus, and
hepatitis G virus by PCR. J Clin Microbiol 2003;41:5273-6.
18. Moss D, Harbison SA, Saul DJ. An easily automated, closed-tube
forensic DNA extraction procedure using a thermostable protei-
nase. Int J Legal Med 2003;117:340-9.
Jong-Han Lee, et al.
Yonsei Med J   http://www.eymj.org    Volume 51   Number 1   January 2010110
REFERENCES
